Frontlight ResearchEarly access
Trial site
The medical centre Kanev Ltd.
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Asthma1 trial
- Crohn's disease1 trial
- Phase
- Phase 24 trials
- Phase 41 trial
- Status
- Not yet recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Spyre Therapeutics, Inc.2 trials
- Chiesi Farmaceutici S.p.A.1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- Sanofi-Aventis Recherche & Developpement1 trial
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis2 recruiting
- Asthma1 recruiting
- Crohn's disease1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026